PUBLISHER: The Business Research Company | PRODUCT CODE: 1945422
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945422
Intravenous fluid transfer drug devices deliver medications and fluids directly into the bloodstream through an IV line while maintaining sterility and preventing contamination, supporting efficient and controlled treatment in critical care settings.
The main product categories in the intravenous fluid transfer drug devices market include infusion bags, infusion devices, and others. Infusion bags are flexible, sterile containers designed to store and deliver fluids, medications, or nutrients directly into a patient's bloodstream through an intravenous (IV) line. The applications include autoimmune disorders, blood-related conditions, cardiovascular disorders, neurological conditions, oncology treatments, and others, and the end users include hospitals, specialized clinics, and others.
Tariffs are impacting the intravenous fluid transfer drug devices market by increasing costs for imported infusion bags, smart infusion pumps, and needleless connectors. Segments such as multi-chamber infusion bags and smart infusion devices are most affected, particularly in Asia-Pacific regions including China and India. The tariffs have led to higher production costs and supply chain disruptions. On the positive side, they are encouraging local manufacturing, material innovation, and investment in domestic production capabilities, which may enhance long-term market resilience.
The intravenous fluid transfer drug devices market research report is one of a series of new reports from The Business Research Company that provides intravenous fluid transfer drug devices market statistics, including intravenous fluid transfer drug devices industry global market size, regional shares, competitors with a intravenous fluid transfer drug devices market share, detailed intravenous fluid transfer drug devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous fluid transfer drug devices industry. This intravenous fluid transfer drug devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intravenous fluid transfer drug devices market size has grown strongly in recent years. It will grow from $7.85 billion in 2025 to $8.35 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to reliance on conventional iv sets, increasing hospital and clinical procedures, limited availability of smart infusion devices, growing awareness of iv therapy benefits, adoption of pvc infusion bags.
The intravenous fluid transfer drug devices market size is expected to see strong growth in the next few years. It will grow to $10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to technological advancements in smart infusion pumps, rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, growth in home healthcare and ambulatory infusion, stricter regulatory and quality standards. Major trends in the forecast period include rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety iv sets, expansion of iv therapy across chronic and critical care treatments, enhanced focus on sterility, accuracy, and flow control.
The rising hospitalization rate is increasingly supporting the expansion of the intravenous fluid transfer drug device market going forward. Higher hospitalization rates are associated with aging populations, chronic diseases, improved diagnostic capabilities, broader healthcare access, and lifestyle-related health conditions. Intravenous fluid transfer drug devices ensure accurate and controlled delivery of fluids and medications directly into the bloodstream of hospitalized patients, supporting effective treatment and patient safety. For example, in March 2023, according to GOV.UK, a UK-based government organization, COVID-19 hospital admission rates in England increased slightly to 10.62 per 100,000 in 2023, while ICU and HDU admissions remained low. Consequently, rising hospitalization rates are reinforcing growth across the intravenous fluid transfer drug device market.
Leading companies in the intravenous fluid transfer drug device market are developing modular and comprehensive infusion systems with features such as auto-identification to improve accuracy, enhance patient safety, and streamline fluid and medication administration. Auto-identification technology automatically verifies and matches medications to the correct patient using barcode scanning or RFID systems. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The system includes upgraded hardware for the Point-of-Care Unit, covering large-volume pumps, syringe pumps, patient-controlled analgesia pumps, respiratory monitoring, and auto-identification modules. It also introduces advanced software with improved cybersecurity and interoperability, allowing seamless integration with electronic medical record systems and supporting connected healthcare delivery.
In May 2024, Nordson Corporation, a US-based precision technology company, acquired Atrion Corporation for an undisclosed amount. Through this acquisition, Nordson Corporation aims to expand and strengthen its medical portfolio by integrating Atrion's advanced infusion and cardiovascular technologies. Atrion Corporation is a US-based technology company specializing in components and devices for intravenous fluid transfer and drug delivery.
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intravenous fluid transfer drug devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intravenous fluid transfer drug devices market consists of sales of infusion pumps, IV bags, tubing sets, connectors, catheters, needles, flow regulators, and syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intravenous Fluid Transfer Drug Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intravenous fluid transfer drug devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intravenous fluid transfer drug devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous fluid transfer drug devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.